{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:12:50Z","timestamp":1777540370635,"version":"3.51.4"},"reference-count":86,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0122835","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T17:50:06Z","timestamp":1428601806000},"page":"e0122835","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Heterologous Prime-Boost Regimens with a Recombinant Chimpanzee Adenoviral Vector and Adjuvanted F4 Protein Elicit Polyfunctional HIV-1-Specific T-Cell Responses in Macaques"],"prefix":"10.1371","volume":"10","author":[{"given":"Clarisse","family":"Lorin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Vanloubbeeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Baudart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u00ebl","family":"Ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffroy","family":"Brauers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9raldine","family":"Clarinval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-No\u00eblle","family":"Donner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marguerite","family":"Koutsoukos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Mettens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Voss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"P Borrow","year":"1994","journal-title":"J Virol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":"The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection","volume":"206","author":"N Goonetilleke","year":"2009","journal-title":"J Exp Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome","volume":"68","author":"RA Koup","year":"1994","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"SG Hansen","year":"2011","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature12519","article-title":"Immune clearance of highly pathogenic SIV infection","volume":"502","author":"SG Hansen","year":"2013","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.it.2006.01.004","article-title":"HIV-specific CD4<sup>+<\/sup> T cells and viremia: who&apos;s in control?","volume":"27","author":"CA Jansen","year":"2006","journal-title":"Trends Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4<sup>+<\/sup> T cells are required for secondary expansion and memory in CD8<sup>+<\/sup> T lymphocytes","volume":"421","author":"EM Janssen","year":"2003","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ni1105","article-title":"CD4<sup>+<\/sup> T cells are required for the maintenance, not programming, of memory CD8<sup>+<\/sup> T cells after acute infection","volume":"5","author":"JC Sun","year":"2004","journal-title":"Nat Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8<sup>+<\/sup> T cells","volume":"107","author":"MR Betts","year":"2006","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.4049\/jimmunol.169.11.6376","article-title":"Presence of HIV-1 Gag-specific IFN-\u03b3<sup>+<\/sup>IL-2<sup>+<\/sup> and CD28<sup>+<\/sup>IL-2<sup>+<\/sup> CD4 T cell responses is associated with nonprogression in HIV-1 infection","volume":"169","author":"MJ Boaz","year":"2002","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e1000917","DOI":"10.1371\/journal.ppat.1000917","article-title":"Perforin expression directly <italic>ex vivo<\/italic> by HIV-specific CD8<sup>+<\/sup> T-cells is a correlate of HIV elite control","volume":"6","author":"AR Hersperger","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.00228-07","article-title":"Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells","volume":"81","author":"S Kannanganat","year":"2007","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"13904","DOI":"10.1128\/JVI.01401-07","article-title":"Preserved central memory and activated effector memory CD4<sup>+<\/sup> T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study","volume":"81","author":"SJ Potter","year":"2007","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2010.09.011","article-title":"Induction of immunity to human immunodeficiency virus type-1 by vaccination","volume":"33","author":"MJ McElrath","year":"2010","journal-title":"Immunity"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development","volume":"10","author":"AJ McMichael","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/COH.0b013e32833cfe4c","article-title":"Novel adenovirus vector-based vaccines for HIV-1","volume":"5","author":"DH Barouch","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys","volume":"16","author":"DH Barouch","year":"2010","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.4049\/jimmunol.181.6.4188","article-title":"Trafficking of antigen-specific CD8<sup>+<\/sup> T lymphocytes to mucosal surfaces following intramuscular vaccination","volume":"181","author":"DR Kaufman","year":"2008","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"11007","DOI":"10.1128\/JVI.05346-11","article-title":"Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeys","volume":"85","author":"H Li","year":"2011","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature07469","article-title":"Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys","volume":"457","author":"J Liu","year":"2009","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"JW Shiver","year":"2002","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2013.09.061","article-title":"Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys","volume":"155","author":"DH Barouch","year":"2013","journal-title":"Cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature10766","article-title":"Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys","volume":"482","author":"DH Barouch","year":"2012","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","article-title":"Safety and efficacy of the HVTN 503\/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","volume":"11","author":"GE Gray","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"MJ McElrath","year":"2008","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"SM Hammer","year":"2013","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1128\/JVI.00450-10","article-title":"Adenovirus-based vaccines: comparison of vectors from three species of <italic>Adenoviridae<\/italic>","volume":"84","author":"H Chen","year":"2010","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.vaccine.2009.03.080","article-title":"Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy","volume":"27","author":"M Dudareva","year":"2009","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1128\/JVI.75.23.11603-11613.2001","article-title":"Replication-defective vector based on a chimpanzee adenovirus","volume":"75","author":"SF Farina","year":"2001","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1089\/hum.2006.17.500","article-title":"Efficacy of severe acute respiratory syndrome vaccine based on a nonhuman primate adenovirus in the presence of immunity against human adenovirus","volume":"17","author":"Y Zhi","year":"2006","journal-title":"Hum Gene Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.4049\/jimmunol.0900317","article-title":"Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens","volume":"182","author":"N Tatsis","year":"2009","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.gt.3302675","article-title":"Chimpanzee-origin adenovirus vectors as vaccine carriers","volume":"13","author":"N Tatsis","year":"2006","journal-title":"Gene Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1016\/j.vaccine.2009.07.050","article-title":"Heterologous prime\/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors","volume":"27","author":"S Santra","year":"2009","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1128\/JVI.78.14.7392-7399.2004","article-title":"Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes","volume":"78","author":"A Reyes-Sandoval","year":"2004","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.4049\/jimmunol.171.12.6774","article-title":"Induction of CD8<sup>+<\/sup> T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers","volume":"171","author":"AR Pinto","year":"2003","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.170.3.1416","article-title":"A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag","volume":"170","author":"JC Fitzgerald","year":"2003","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/IAI.00740-09","article-title":"Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8<sup>+<\/sup> T-cell responses","volume":"78","author":"A Reyes-Sandoval","year":"2010","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.4049\/jimmunol.1202861","article-title":"Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8<sup>+<\/sup> T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization","volume":"190","author":"KM Quinn","year":"2013","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e57726","DOI":"10.1371\/journal.pone.0057726","article-title":"Safety and immunogenicity of heterologous prime-boost immunisation with <italic>Plasmodium falciparum<\/italic> malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults","volume":"8","author":"C Ogwang","year":"2013","journal-title":"PLoS One"},{"key":"ref41","first-page":"2836","article-title":"Protective CD8","volume":"4","author":"KJ Ewer","year":"2013","journal-title":"Nat Commun"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.vaccine.2010.10.041","article-title":"Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates","volume":"29","author":"S Capone","year":"2011","journal-title":"Vaccine"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/erv.13.15","article-title":"Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials","volume":"12","author":"S Capone","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/cid\/ciq160","article-title":"An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4<sup>+<\/sup> T cell responses in seronegative volunteers","volume":"52","author":"E Van Braeckel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.vaccine.2013.10.030","article-title":"Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: A randomised placebo-controlled study","volume":"32","author":"T Harrer","year":"2013","journal-title":"Vaccine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CVI.00617-13","article-title":"Immunogenicity and safety of a booster dose of an investigational adjuvanted polyprotein HIV-1 vaccine in healthy adults and effect of administration of chloroquine","volume":"21","author":"G Leroux-Roels","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.4049\/jimmunol.175.6.3502","article-title":"Vaccine-induced CD8<sup>+<\/sup> central memory T cells in protection from simian AIDS","volume":"175","author":"M Vaccari","year":"2005","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.168.1.29","article-title":"Development and homeostasis of T cell memory in rhesus macaque","volume":"168","author":"CJ Pitcher","year":"2002","journal-title":"J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8<sup>+<\/sup> T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"P Kiepiela","year":"2007","journal-title":"Nat Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.4161\/hv.21760","article-title":"HIV vaccines: can CD4<sup>+<\/sup> T cells be of help?","volume":"8","author":"E Van Braeckel","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/14760584.6.5.723","article-title":"GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives","volume":"6","author":"N Gar\u00e7on","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/erv.11.29","article-title":"Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems","volume":"10","author":"N Gar\u00e7on","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1002\/eji.201242624","article-title":"T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV\/NDK challenge virus load","volume":"42","author":"Y Roshorm","year":"2012","journal-title":"Eur J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"9420","DOI":"10.1128\/JVI.01456-13","article-title":"Immunological and virological analyses of rhesus macaques immunized with chimpanzee adenoviruses expressing the simian immunodeficiency virus Gag\/Tat fusion protein and challenged intrarectally with repeated low doses of SIVmac","volume":"87","author":"B Cervasi","year":"2013","journal-title":"J Virol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e31208","DOI":"10.1371\/journal.pone.0031208","article-title":"Phase Ia clinical evaluation of the safety and immunogenicity of the <italic>Plasmodium falciparum<\/italic> blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors","volume":"7","author":"SH Sheehy","year":"2012","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"115ra2","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"S Colloca","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/JVI.02058-12","article-title":"Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors","volume":"87","author":"P Penaloza-Macmaster","year":"2013","journal-title":"J Virol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1073\/pnas.1215393110","article-title":"DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge","volume":"110","author":"V Patel","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"e86254","DOI":"10.1371\/journal.pone.0086254","article-title":"Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques","volume":"9","author":"V Kulkarni","year":"2014","journal-title":"PLoS One"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1016\/j.vaccine.2011.05.083","article-title":"Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines","volume":"29","author":"VK Pillai","year":"2011","journal-title":"Vaccine"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in vivo and maintain activated CD8<sup>+<\/sup> T cells: implications for their use as vaccines","volume":"110","author":"N Tatsis","year":"2007","journal-title":"Blood"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1128\/JVI.02345-08","article-title":"Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens","volume":"83","author":"P Mooij","year":"2009","journal-title":"J Virol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"12071","DOI":"10.1128\/JVI.01261-07","article-title":"Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines","volume":"81","author":"S Kannanganat","year":"2007","journal-title":"J Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4049\/jimmunol.176.3.1465","article-title":"Protein vaccines induce uncommitted IL-2-secreting human and mouse CD4 T cells, whereas infections induce more IFN-\u03b3-secreting cells","volume":"176","author":"AA Divekar","year":"2006","journal-title":"J Immunol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1084\/jem.20031598","article-title":"HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4<sup>+<\/sup> T cells endowed with proliferative capacity","volume":"198","author":"SA Younes","year":"2003","journal-title":"J Exp Med"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"10900","DOI":"10.1128\/JVI.77.20.10900-10909.2003","article-title":"Diminished proliferation of human immunodeficiency virus-specific CD4<sup>+<\/sup> T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2","volume":"77","author":"C Iyasere","year":"2003","journal-title":"J Virol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"F Sallusto","year":"1999","journal-title":"Nature"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1016\/j.vaccine.2013.05.021","article-title":"Polyfunctional CD4<sup>+<\/sup> T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine","volume":"31","author":"E Van Braeckel","year":"2013","journal-title":"Vaccine"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.4049\/jimmunol.0803928","article-title":"Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses","volume":"182","author":"A S\u00e1ez-Ciri\u00f3n","year":"2009","journal-title":"J Immunol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1128\/JVI.00996-12","article-title":"Gag-specific cellular immunity determines <italic>in vitro<\/italic> viral inhibition and <italic>in vivo<\/italic> virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys","volume":"86","author":"KE Stephenson","year":"2012","journal-title":"J Virol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nm.1935","article-title":"Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge","volume":"15","author":"SG Hansen","year":"2009","journal-title":"Nat Med"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1128\/JVI.00531-12","article-title":"Elite controllers with low to absent effector CD8<sup>+<\/sup> T cell responses maintain highly functional, broadly directed central memory responses","volume":"86","author":"ZM Ndhlovu","year":"2012","journal-title":"J Virol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1128\/JVI.02563-09","article-title":"Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8<sup>+<\/sup> T lymphocytes","volume":"84","author":"DR Kaufman","year":"2010","journal-title":"J Virol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1128\/JVI.01157-10","article-title":"Mucosal trafficking of vector-specific CD4<sup>+<\/sup> T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5","volume":"84","author":"K Masek-Hammerman","year":"2010","journal-title":"J Virol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/nm1201-1320","article-title":"Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques","volume":"7","author":"IM Belyakov","year":"2001","journal-title":"Nat Med"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2796.2008.02051.x","article-title":"Antiviral CD8<sup>+<\/sup> T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6","volume":"265","author":"M Genesc\u00e0","year":"2009","journal-title":"J Intern Med"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"11181","DOI":"10.1128\/JVI.01433-08","article-title":"With minimal systemic T-cell expansion, CD8<sup>+<\/sup> T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus","volume":"82","author":"M Genesc\u00e0","year":"2008","journal-title":"J Virol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-4690-8-24","article-title":"Strong mucosal immune responses in SIV infected macaques contribute to viral control and preserved CD4+ T-cell levels in blood and mucosal tissues","volume":"8","author":"T Schultheiss","year":"2011","journal-title":"Retrovirology"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"e3577","DOI":"10.1371\/journal.pone.0003577","article-title":"Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status","volume":"3","author":"JW Critchfield","year":"2008","journal-title":"PLoS One"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1182\/blood-2008-10-182709","article-title":"Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control","volume":"113","author":"AL Ferre","year":"2009","journal-title":"Blood"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"9860","DOI":"10.1073\/pnas.0503463102","article-title":"Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors","volume":"102","author":"S Sankaran","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.164.3.1602","article-title":"HIV-1-specific mucosal CD8<sup>+<\/sup> lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi","volume":"164","author":"R Kaul","year":"2000","journal-title":"J Immunol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"e13579","DOI":"10.1371\/journal.pone.0013579","article-title":"Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)","volume":"5","author":"L Peiperl","year":"2010","journal-title":"PLoS One"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"e41936","DOI":"10.1371\/journal.pone.0041936","article-title":"A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults","volume":"7","author":"MC Keefer","year":"2012","journal-title":"PLoS One"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0122835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T17:49:41Z","timestamp":1598896181000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0122835"}},"subtitle":[],"editor":[{"given":"Roger","family":"Le Grand","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,9]]},"references-count":86,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0122835","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,9]]}}}